Paulina Rychenkova

Paulina Rychenkova is an accomplished professional with extensive experience in business development, innovation, and venture capital, currently serving in a strategic role at AbbVie. As the founder of CureSHANK, Paulina has pioneered initiatives in healthcare, while previous roles include Senior Manager of Innovation and Commercialization at Argonne National Laboratory and Vice President at Sandbox Industries, where oversight of a significant healthcare fund took place. Advocacy for Phelan-McDermid Syndrome for nearly eight years highlights Paulina's commitment to impactful research, and a solid financial foundation was established as CFO at The Albermarle Group. Educational qualifications include a PhD in Theoretical Physics and a Master’s Degree in Applied Mathematics from the University of Cambridge, augmented by a Bachelor's Degree in Physics and Mathematics from Hope College.